As states tighten oversight, private equity’s healthcare deals decline

New state oversight laws are slowing private equity's ability to acquire healthcare assets, causing a decline in both the number and value of such deals compared to previous years. The report attributes this slowdown to increased state scrutiny, with multiple states passing or proposing laws that restrict how private equity can operate or gain control over medical practices.